123489-95-2

Upstream product

• 49826-08-6 1-hydroxy-2-(2-hydroxyethyl)cyclopent-3-ene 

Downstream Products

• 113007-90-2 dl-trans-2-<2-<(phenylsulfonyl)amino>cyclopent-4-enyl>ethanol triphenylmethyl ether 
• 112917-66-5 dl-methyl (1α,2α,3β,5α)-7-<3-<(phenylsulfonyl)amino>-6-thiabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoate 
• 112917-66-5 dl-methyl (1β,2α,3β,5β)-7-<3-<(phenylsulfonyl)amino>-6-thiabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoate 
• 112917-64-3 dl-(1α,2α,3β,5α)-7-<3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoic acid methyl ester 
• 112968-64-6 dl-methyl (1β,2α,3β,5β)-7-<3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoate 
• 123539-07-1 dl-(1α,2α,3β,5α)-7-<3-<(phenylsulfonyl)amino>-6-thiabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoic acid 
• 112967-21-2 dl-(1β,2α,3β,5β)-7-<3-<(phenylsulfonyl)amino>-6-thiabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoic acid 
• 112967-17-6 dl-(1α,2α,3β,5α)-7-<3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoic acid 
• 112968-63-5 dl-(1β,2α,3β,5β)-7-<3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hex-2-yl>-5(Z)-heptenoic acid 
• 113007-89-9 dl-trans-2-(2-aminocyclopent-4-enyl)ethanol triphenylmethyl ether 
• 113007-92-4 dl-(1α,2α,3β,5α)-2-(formylmethyl)-3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hexane 
• 123539-05-9 dl-(1β,2α,3β,5β)-2-(formylmethyl)-3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hexane 
• 113084-33-6 dl-(1α,2α,3β,5α)-2-(hydroxyethyl)-3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hexane 
• 113084-34-7 dl-(1β,2α,3β,5β)-2-(hydroxyethyl)-3-<(phenylsulfonyl)amino>-6-oxabicyclo<3.1.0>hexane 

Relevant academic research and scientific papers

Synthesis of Thromboxane Receptor Antagonists with Bicyclohexane Ring Systems

Thromboxane A2 receptor antagonists 11a, 15a, 26a, 30a, 34a, 36a, 46a, 52a, 61a, 72a, and 82a, which contain 6-oxabicyclohexane, 6-thiabicyclohexane, bicyclohexane, or 6,6-dimethylbicyclohexane ring systems with hept